Authors: Laufman, LR Spiridonidis, CH Pritchard, J Roach, R Zangmeister, J Larrimer, N Moore, T Segal, M Jones, J Patel, T Gutterman, L Carman, L Colborn, D Kuebler, JP

Citation: Lr. Laufman et al., Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: A phase II trial, ANN ONCOL, 12(9), 2001, pp. 1259-1264

Authors: Spiridonidis, CH Laufman, LR Carman, L Moore, T Blair, S Jones, J George, C Patel, T Roach, R Rupert, R Zangmeister, J Colborn, D Kuebler, JP

Citation: Ch. Spiridonidis et al., Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial, ANN ONCOL, 12(1), 2001, pp. 89-94

Authors: Samlowski, WE Gundacker, H Kuebler, JP Giguere, JK Mills, GM Schuller, DE Ensley, JF

Citation: We. Samlowski et al., Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group Phase II study, INV NEW DR, 19(4), 2001, pp. 311-315

Authors: Kuebler, JP King, GW Triozzi, P Moore, T Kraut, EH

Citation: Jp. Kuebler et al., Phase II study of pyrazoloacridine in metastatic renal cell carcinoma, INV NEW DR, 19(4), 2001, pp. 327-328

Authors: Kraut, EH Balcerzak, SP Young, D O'Rourke, MA Petrus, JJ Kuebler, JP Mayernik, DG

Citation: Eh. Kraut et al., A phase II study of 9-aminocamptothecin in patients with refractory breastcancer, CANCER INV, 18(1), 2000, pp. 28-31

Authors: Macdonald, JS Jacobson, JL Ketchel, SJ Weiss, G Taylor, S Mills, G Kuebler, JP Rivkin, S Conrad, M

Citation: Js. Macdonald et al., A phase II trial of topotecan in esophageal carcinoma: A Southwest Oncology Group study (SWOG 9339), INV NEW DR, 18(2), 2000, pp. 199-202